NICTN are delighted Belfast has received renewal of Experimental Cancer Medicine Centre (ECMC) status following an international review process. Belfast ECMC is a collaboration of the Centre for Cancer Research and Cell Biology, QUB, and Belfast HSC Trust. This brings together science and early phase clinical research to support innovative treatments to transform patients’ lives. Belfast ECMC is jointly funded by HSC Research and Development Division and Cancer Research UK. Belfast ECMC integrates fully with the wider ECMC Network, comprised of 20 Centres within the UK.
Posted in Uncategorized.